Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
3IN 3i Infrastructure	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 394 +1.0%		Hold
ACN Accenture	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin McVeigh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$183.53 +3.6%		Buy
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$23.21 -0.6%	C$30.50 ➝ C$31.50	Outperform
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$23.21 -0.6%	C$26.00 ➝ C$27.00	Buy
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$23.21 -0.6%	C$27.50 ➝ C$28.00	Buy
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$23.21 -0.6%	C$30.00 ➝ C$30.25	Buy
AEE Ameren	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.58 -0.7%	$124.00 ➝ $113.00	Outperform
AEP American Electric Power	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Weisel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.64 -0.6%	$140.00 ➝ $131.00	Sector Perform
AKAM Akamai Technologies	Target Raised by	President Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$106.35 -1.9%	$150.00 ➝ $168.00	Buy
ALDX Aldeyra Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.23 -6.8%	$2.00	Neutral
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ALLY Ally Financial	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Donald Fandetti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.63 -0.5%	$55.00 ➝ $42.00	Overweight ➝ Equal Weight
ALNY Alnylam Pharmaceuticals	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.74 -2.9%	$375.00 ➝ $369.00	Overweight
ALNY Alnylam Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$246.74 -2.9%		Neutral
AMPL Amplitude	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.85 +1.5%	$13.00 ➝ $18.00	Overweight
AMT American Tower	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$163.95 -2.0%	$198.00 ➝ $199.00	Overweight
AMZN Amazon.com	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$249.15 +1.0%	$335.00 ➝ $360.00	Buy
ANAB AnaptysBio	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.26 -0.2%	$70.00 ➝ $60.00	Overweight
ANET Arista Networks	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.09 +0.6%	$250.00	Outperform
ANNX Annexon	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.24 +2.5%	$14.00 ➝ $15.00	Overweight
APH Amphenol	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.42 +0.1%	$105.00	Outperform
APPS Digital Turbine	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.10 -4.7%	$15.00	Outperform
ARX Accelerant	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Kligerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.74 +0.0%	$30.00 ➝ $20.25	Buy ➝ Hold
ASML ASML	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,811.67 -1.2%		Neutral
ATI ATI	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$189.59 +0.3%	$275.00 ➝ $240.00	Overweight
ATZ Aritzia	Target Lowered by	Ventum Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$119.88 -2.2%	C$186.00 ➝ C$146.00	Neutral
AVAP Avation	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 142 +1.4%	GBX 270 ➝ GBX 310	Buy
AXP American Express	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Gerlinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.21 -0.4%	$355.00 ➝ $340.00	Neutral
BA Boeing	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$186.27 -0.8%		Outperform
BA Boeing	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$186.27 -0.8%		Outperform
BANC Banc of California	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry McEvoy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.22 -0.5%	$23.00 ➝ $22.00	Overweight
BCRX BioCryst Pharmaceuticals	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.33 +0.7%	$12.00 ➝ $13.00	Neutral
BKH Black Hills	Initiated by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matvey Tayts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.22 -0.1%	$69.00	Hold
BKNG Booking	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.92 +0.4%	$242.00 ➝ $216.00	Buy
BKR Baker Hughes	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.90 -1.8%	$72.00 ➝ $69.00	Neutral
BLDP Ballard Power Systems	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.04 -2.9%	$6.50 ➝ $2.15	Neutral
BLDP Ballard Power Systems	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.04 -2.9%		Neutral
BLSM BlossomHill Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.66 -12.7%		Buy
BMEA Biomea Fusion	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.33 +5.6%		Market Outperform
BP BP	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Margolin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.05 +1.2%	$57.00	Equal Weight ➝ Overweight
BRO Barksdale Resources	Upgraded by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$0.27 -6.9%	C$0.25 ➝ C$0.30	Sector Perform ➝ Speculative Buy
I've seen this movie before (last time: 17,556%) (Ad) My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called to our community before the big move happened… And right now, I'm making my next big call. It's a coin trading under $1.00… one most investors have never even heard of. But the world's largest bank is already building on it. It has a burn mechanism wired directly to institutional usage… meaning the more the big money uses it, the more rare it becomes. And its biggest supply cut in history happened earlier this year… Click to see my #1 pick.
BROS Dutch Bros	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Bittner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.60 +1.3%	$82.00 ➝ $66.00	Outperform
BROS Dutch Bros	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Bittner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.60 +1.3%		Positive
BRZE Braze	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.10 +8.4%	$38.00	Overweight
BTE Baytex Energy	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.43 +1.6%	C$8.50 ➝ C$9.50	Outperform
BWXT BWX Technologies	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andre Madrid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -0.4%	$235.00	Buy
BWXT BWX Technologies	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ciarmoli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -0.4%	$192.00	Buy
BWXT BWX Technologies	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -0.4%	$250.00 ➝ $210.00	Buy
BWXT BWX Technologies	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$137.48 -0.4%		Outperform
BWXT BWX Technologies	Target Lowered by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Grampp Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.48 -0.4%	$250.00 ➝ $220.00	Outperform
BYN Banyan Gold	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.91 -1.0%	C$3.00	Outperform
CARR Carrier Global	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.95 -0.8%	$71.00 ➝ $64.00	Hold
CARR Carrier Global	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Ritchie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.95 -0.8%	$85.00 ➝ $74.00	Buy
CAS Cascades	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$18.31 -1.4%	C$17.50 ➝ C$23.00
CC Chemours	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Roberts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.59 -2.2%	$20.00 ➝ $18.00	Outperform
CCI Crown Castle	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.62 -0.7%	$84.00 ➝ $86.00	Overweight
CCL Carnival	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Clarke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 -2.0%	$28.70	Market Perform
CCL Carnival	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Stathoulopoulos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 -2.0%	$33.00 ➝ $28.00	Positive
CCL Carnival	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 -2.0%	$39.00 ➝ $38.00	Outperform
CCL Carnival	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Xian Siew Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 -2.0%	$33.00 ➝ $31.00	Outperform
CCL Carnival	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.60 -2.0%	$36.00	Buy
CE Celanese	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.56 -0.6%	$60.00 ➝ $58.00	Buy
CELC Celcuity	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.52 +2.8%	$140.00 ➝ $134.00	Buy
CERT Certara	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.20 -0.6%	$10.00	Buy ➝ Neutral
CIEN Ciena	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$352.99 -0.5%	$440.00	Outperform
CLS Celestica	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$361.89 -1.2%	$520.00	Outperform
CMI Cummins	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Fisher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$517.31 -0.8%	$741.00
CMI Cummins	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Fisher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$517.31 -0.8%	$835.00 ➝ $741.00	Buy
CNTB Connect Biopharma	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.10 +10.9%	$5.00	Buy
CNXC Concentrix	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Morison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.95 +0.3%	$45.00	Buy
COLB Columbia Banking System	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry McEvoy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.60 -0.3%	$34.00 ➝ $32.00	Equal Weight
CPK Chesapeake Utilities	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Constantine Lednev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.73 +0.4%	$134.00 ➝ $136.00	Equal Weight
CRL Charles River Laboratories International	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$295.91 0.0%	$357.00	Buy
CRS Carpenter Technology	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$389.25 -0.6%	$540.00 ➝ $430.00	Equal Weight
CRWV CoreWeave	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.12 +1.4%		Outperform
CSCO Cisco Systems	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.63 +0.6%	$110.00	Market Perform
CTAS Cintas	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Carrington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$195.06 -1.4%	$180.00 ➝ $181.00	Sell
CTNM Contineum Therapeutics	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Matteis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.42 +16.7%	$28.00
CVCO Cavco Industries	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Batory Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$560.26 +0.7%	$720.00	Outperform
CVE Cenovus Energy	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$44.24 +0.6%	C$60.00	Outperform
CVNA Carvana	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Nagel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.72 -1.4%	$450.00 ➝ $90.00	Outperform
DASH DoorDash	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$183.55 -1.9%		Market Outperform
DBVT DBV Technologies	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.76 +1.8%		Market Outperform
DC Dakota Gold	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.09 -1.9%	$10.75	Buy
DCGO DocGo	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.40 +8.6%		Buy
DD DuPont de Nemours	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.00 -0.1%	$159.00 ➝ $153.00	Neutral
DKS DICK'S Sporting Goods	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$134.48 -0.2%		Neutral
DUK Duke Energy	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$114.17 0.0%	$146.00 ➝ $131.00
DYN Dyne Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.11 -0.6%	$50.00 ➝ $32.00	Buy
DYN Dyne Therapeutics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.11 -0.6%	$38.00	Buy
DYN Dyne Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.11 -0.6%		Buy
Trump To Relaunch USD? (Ad) President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may be a bid to reset the US dollar. Porter Stansberry says the meeting, attended by figures like Elon Musk, Jensen Huang and Larry Fink, connects to a 13-nation pact designed to cut China out of a massive investment wave. Watch the free documentary to see the five critical assets now.
DYN Dyne Therapeutics	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Tsai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.11 -0.6%	$50.00	Buy
DYN Dyne Therapeutics	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Matteis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.11 -0.6%	$37.00
EFX Equifax	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Griffin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.23 -2.6%	$179.00 ➝ $160.00	Market Perform
ELAN Elanco Animal Health	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Dechert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.45 -0.7%		Overweight
EMN Eastman Chemical	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.86 -1.3%	$81.00 ➝ $76.00	Buy
EMR Emerson Electric	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$155.40 -1.2%	$169.00 ➝ $174.00	Hold
ENB Enbridge	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.53 -0.3%	$50.00
ENGGY Enagas	Downgraded by	Oddo Bhf Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.26 -1.6%		Neutral
ETL E3 Lithium	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$0.70 -6.0%	C$4.00 ➝ C$3.75
EVPL Everplay Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 457 +7.9%	GBX 470	Buy
EXPD Expeditors International of Washington	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hugo Watkins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$184.72 -1.8%	$180.00	Neutral
EXPE Expedia Group	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$263.36 -1.1%	$309.00 ➝ $288.00	Hold
FDX FedEx	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$285.41 -0.7%	$269.80 ➝ $300.00	Neutral
FHB First Hawaiian	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Spahr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.62 -0.8%	$28.00 ➝ $26.00	Underweight
FHN First Horizon	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry McEvoy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.02 -0.3%	$28.00 ➝ $25.00	Equal Weight
FICO Fair Isaac	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Griffin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$593.43 -4.0%	$1,550.00 ➝ $1,150.00	Outperform
FICO Fair Isaac	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$593.43 -4.0%	$1,400.00 ➝ $700.00	Buy ➝ Neutral
FICO Fair Isaac	Target Set by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$593.43 -4.0%	$700.00
FICO Fair Isaac	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$593.43 -4.0%	$1,350.00 ➝ $950.00	Overweight
FICO Fair Isaac	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$593.43 -4.0%	$1,700.00 ➝ $935.00	Overweight
FLYW Flywire	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.50 +1.0%	$25.00	Outperform
FORM FormFactor	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.31 +9.6%	$200.00	Buy
FOXF Fox Factory	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter McGoldrick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.37 -1.8%	$25.00
FRBT Forbright	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry McEvoy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.03 -0.2%	$22.00 ➝ $21.00	Overweight
FSLR First Solar	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dimple Gosai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.16 -1.0%	$260.00 ➝ $251.00	Overweight
FTRE Fortrea	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.95 +1.1%	$22.00	Neutral
FTS Fortis	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$75.17 -0.1%	C$82.00 ➝ C$76.00	Overweight
FTT Finning International	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$109.04 +0.7%	C$127.00	Buy
FVA ForViva	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 147 +5.0%	GBX 190	Buy
FVA ForViva	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 147 +5.0%	GBX 135	Hold
GBTG Global Business Travel Group	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jake Fuller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.50		Neutral
GE GE Aerospace	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$312.94 -1.6%	$390.00 ➝ $380.00	Overweight
GEI Gibson Energy	Target Raised by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$30.44 +0.5%	C$34.00 ➝ C$35.00
GLW Corning	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$154.00 -3.0%	$140.00	Market Perform
GNRC Generac	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.10 -2.4%	$285.00 ➝ $290.00	Buy
GNRC Generac	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Bagri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.10 -2.4%	$300.00 ➝ $232.00	Neutral
GO Grocery Outlet	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Ohmes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.25 +2.7%	$12.50 ➝ $15.00	Neutral ➝ Buy
GPK Graphic Packaging	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.06 -1.6%	$11.00 ➝ $10.00	Sector Perform
GRG Greggs	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,028 +8.2%	GBX 1,910	Hold
HAWK HawkEye 360	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.12 -1.7%	$33.00 ➝ $28.00	Outperform
HBM Hudbay Minerals	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$38.04 -0.8%	C$42.00 ➝ C$43.00
HBM Hudbay Minerals	Target Raised by	Haywood Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$38.04 -0.8%	C$43.00 ➝ C$45.00
HE Hawaiian Electric Industries	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.94 -1.6%	$12.00 ➝ $9.00	Equal Weight
HEI Heico	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$303.43 -1.2%	$350.00 ➝ $335.00	Equal Weight
HNGE Hinge Health	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.51 +2.4%	$97.00 ➝ $115.00	Buy
HOOD Robinhood Markets	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cyprys Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.50 -3.2%	$150.00	Overweight
HTO H2O America	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.63 0.0%	$67.00 ➝ $66.00	Overweight
HUN Huntsman	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.41 +0.3%	$11.00 ➝ $9.00	Neutral
HWM Howmet Aerospace	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$226.43 -2.0%		Buy
HWM Howmet Aerospace	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$226.43 -2.0%	$315.00 ➝ $255.00	Equal Weight
The $7 trillion infrastructure buildout in progress (Ad) McKinsey projects nearly $7 trillion could pour into a new global infrastructure buildout by 2030 - larger than the annual economies of Japan, Germany, and India combined. Weiss Ratings' Chief Venture Strategist Chris Graebe says surging demand for a resource he calls Computium is the trigger behind this massive spending wave, and he's identified the lesser-known companies positioned to benefit. Graebe points to October 12 as a potential turning point for this opportunity. Watch the presentation to see which companies could benefit
HXL Hexcel	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.16 -0.2%	$120.00 ➝ $105.00	Overweight
ICLR Icon	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.99 -0.2%	$195.00	Neutral
IDT IDT	Target Raised by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mikhail Paramonov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.98 +5.9%	$75.00 ➝ $85.00	Buy
IMMX Immix Biopharma	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.40 -1.3%		Market Outperform
IMNM Immunome	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Azar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.51 -1.7%	$24.00
INIO Innio	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Ritchie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.13 -1.4%	$35.00
INSM Insmed	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eliana Merle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.14 -1.3%	$237.00 ➝ $207.00	Overweight
IOVA Iovance Biotherapeutics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yanan Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.82 +2.6%	$14.00 ➝ $18.00	Overweight
IPX IperionX	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Pipes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.82 -8.1%	$52.00 ➝ $34.00	Buy
IQV IQVIA	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$269.95 +0.4%	$345.00	Buy
ITW Illinois Tool Works	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$257.87 -3.4%	$287.00 ➝ $281.00	Hold
JAZZ Jazz Pharmaceuticals	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.52 -0.4%	$325.00	Buy
JBSS John B. Sanfilippo & Son	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.51 -1.2%	$109.00	Buy
JCI Johnson Controls International	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$148.90 -0.4%	$180.00 ➝ $178.00	Buy
JCI Johnson Controls International	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$148.90 -0.4%	$186.00 ➝ $191.00	Buy
JD JD Sports Fashion	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 80.02 +1.1%	GBX 75	Hold
JDSPY JD Sports Fashion	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.02 -0.8%		Neutral
JKHY Jack Henry & Associates	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.24 -2.0%	$170.00 ➝ $158.00	Equal Weight
JKHY Jack Henry & Associates	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.24 -2.0%	$178.00	Outperform
KEL Kelt Exploration	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$10.33 +1.0%	C$13.25	Outperform
KIE Kier Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 310.60 +0.1%	GBX 300 ➝ GBX 370	Buy
KMX CarMax	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$45.00 ➝ $50.00	Underperform
KMX CarMax	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Babcock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$61.00 ➝ $67.00	Equal Weight
KMX CarMax	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$50.00 ➝ $60.00	Hold
KMX CarMax	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Percoco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$47.00 ➝ $53.00	Equal Weight
KMX CarMax	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Spak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$57.00 ➝ $62.00	Neutral
KMX CarMax	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$33.00 ➝ $48.00	Underperform
KMX CarMax	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$45.00 ➝ $56.00	Sector Perform
KMX CarMax	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Kennison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.51 -6.3%	$64.00 ➝ $70.00	Outperform
KNSA Kiniksa Pharmaceuticals International	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eva Fortea-Verdejo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.61 -1.5%	$87.00	Overweight
KOD Kodal Minerals	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 0.28 +1.1%	GBX 1.20	Speculative Buy
KOD Kodiak Sciences	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Newkirk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.80 +4.0%	$103.00	Neutral
KTOS Kratos Defense & Security Solutions	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.69 -0.8%		Buy
KTOS Kratos Defense & Security Solutions	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.69 -0.8%	$68.00
KUBTY Kubota	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$86.17 -0.6%		Equal Weight ➝ Underweight
LBRT Liberty Energy	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.28 -0.9%	$35.00 ➝ $31.00	Buy
LBRT Liberty Energy	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.28 -0.9%	$28.50 ➝ $27.50	Buy
LEVI Levi Strauss & Co.	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.67 -0.4%	$25.00 ➝ $22.00	Neutral
LEVI Levi Strauss & Co.	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.67 -0.4%	$27.00	Buy
LGN Logan Energy	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.16 +2.7%	C$1.75	Outperform
LIO Liontrust Asset Management	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 308 +18.2%	GBX 360 ➝ GBX 390	Buy
LITE Lumentum	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$971.26 -0.2%	$1,220.00	Outperform
LORD Lords Group Trading	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 12.66 -7.9%	GBX 40	Buy
LW Lamb Weston	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.74 -3.5%	$52.00 ➝ $46.00	Neutral
LYB LyondellBasell Industries	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.46 -1.2%	$72.00 ➝ $63.00	Buy ➝ Neutral
MATX Matson	Initiated by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sergey Glinyanov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.33 -3.1%	$260.00	Buy
MBLY Mobileye Global	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.39 -2.4%	$14.00 ➝ $9.00	Overweight ➝ Equal Weight
MDB MongoDB	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$430.00	Buy
MDB MongoDB	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$398.00 ➝ $372.00	Equal Weight
MDB MongoDB	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$465.00 ➝ $385.00	Buy
"How Much Can I Actually Spend Each Year With $2.5M Saved?" (Ad) Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors. Take the free quiz to get matched with a fiduciary advisor
MDB MongoDB	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$450.00 ➝ $420.00	Outperform
MDB MongoDB	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$465.00	Outperform
MDB MongoDB	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$519.00	Market Outperform
MDB MongoDB	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$410.00 ➝ $375.00	Neutral
MDB MongoDB	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%		Overweight
MDB MongoDB	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$470.00	Overweight
MDB MongoDB	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.61 +3.4%	$465.00 ➝ $415.00	Buy
MDT Medtronic	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.45 -0.7%	$110.00	Buy
MEDP Medpace	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$624.18 +0.3%	$405.00 ➝ $673.00	Sell ➝ Neutral
MMM 3M	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicole Deblase Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.38 -2.4%	$192.00 ➝ $194.00	Hold
MRNA Moderna	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.57 -5.4%	$60.00 ➝ $80.00	Neutral ➝ Sell
MS Morgan Stanley	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$188.81 -2.1%	$235.00 ➝ $210.00	Neutral
MSFT Microsoft	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$512.90 +0.8%	$550.00 ➝ $610.00	Overweight
MTL Mullen Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$27.30 +0.3%	C$30.00 ➝ C$32.00
MTN Vail Resorts	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Grambling Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.29 -2.8%	$147.00 ➝ $142.00	Equal Weight
NBIS Nebius Group	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$235.88 -0.6%		Outperform
NEE NextEra Energy	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.88 0.0%	$110.00 ➝ $99.00	Outperform
NEOG Neogen	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.80 +0.5%	$12.00 ➝ $14.00	Buy
NESR National Energy Services Reunited	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.47 -3.9%	$44.00	Overweight
NESR National Energy Services Reunited	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.47 -3.9%	$44.00
NICE NiCE	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Horan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.27 +4.2%	$150.00	Market Perform ➝ Outperform
NOV NOV	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.75 -1.2%	$22.00 ➝ $21.00	Neutral
NPK National Presto Industries	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$148.19 +1.0%	$162.00
NSC Norfolk Southern	Target Raised by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$309.77 -1.0%	$358.00 ➝ $360.00
NTAP NetApp	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$210.08 +0.4%	$200.00 ➝ $220.00	Neutral
NTB Bank of N.T. Butterfield & Son	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Rutschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.91 -0.9%	$61.00 ➝ $65.00	Equal Weight
NUVB Nuvation Bio	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.61 -0.1%	$12.00	Market Outperform ➝ Buy
NXT Nextpower	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dimple Gosai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.93 -1.7%	$116.00 ➝ $110.00	Overweight
OLN Olin	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.51 +0.5%	$19.00 ➝ $17.00	Neutral
OLN Olin	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Duffy Fischer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.51 +0.5%	$18.00
OVV Ovintiv	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$57.80 -1.7%	$83.00 ➝ $91.00	Outperform
PAYS Paysign	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.48 +4.9%	$12.00 ➝ $15.00	Buy
PEP PepsiCo	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.72 -1.5%	$142.00 ➝ $133.00
PEP PepsiCo	Target Lowered by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$126.72 -1.5%	$150.00 ➝ $135.00
PG Procter & Gamble	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Moskow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.54 -1.9%	$150.00	Hold
PGNY Progyny	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stan Berenshteyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.19 +1.6%	$37.00	Overweight
PNFP Pinnacle Financial Partners	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry McEvoy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.71 +0.2%	$118.00	Equal Weight ➝ Overweight
POR Portland General Electric	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward DeArias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.70 +0.5%	$52.00 ➝ $47.00	Market Perform
PPG PPG Industries	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.53 -1.4%	$121.00 ➝ $118.00	Neutral
PPTA Perpetua Resources	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.57 +0.2%	$43.50	Buy
PSQL Pasqal	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.36 +3.6%	$16.00	Buy
PSQL Pasqal	Target Set by	Williams Trading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.36 +3.6%	$16.00
PSX Phillips 66	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$256.07 +1.5%	$255.00 ➝ $295.00	Buy
PSX Phillips 66	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Neil Mehta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$256.07 +1.5%	$245.00 ➝ $274.00	Neutral
QMLS QumulusAI	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Papanastasiou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.48 -0.8%	$23.00	Buy
QTRH Quarterhill	Target Lowered by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.90 -2.4%	C$4.50 ➝ C$4.00
QURE uniQure	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.16 -1.4%	$46.00 ➝ $31.00	Neutral
RACE Ferrari	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edouard Aubin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.17 -2.2%	$460.00 ➝ $456.00	Overweight
RCI.B Rogers Communications	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$43.82 0.0%	C$62.00 ➝ C$59.00
RCUS Arcus Biosciences	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Driscoll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.90 +1.0%	$43.00	Outperform
REXR Rexford Industrial Realty	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$36.29 -3.0%		Overweight
RHIM RHI Magnesita	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,105 +10.1%	GBX 4,000	Buy
RNAC Cartesian Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.21 -0.4%	$25.00	Buy
ROK Rockwell Automation	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$435.55 +0.9%	$469.00 ➝ $500.00	Hold
ROK Rockwell Automation	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$435.55 +0.9%	$510.00 ➝ $485.00	Neutral
RRX Regal Rexnord	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$155.40 -0.3%	$216.00
RUS Russel Metals	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$90.48 +4.1%	C$92.00 ➝ C$107.00
RZLT Rezolute	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Brims Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.14 +1.2%	$9.00	Buy
SAGA Saga	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 787 +22.8%	GBX 1,025 ➝ GBX 1,130	Buy
SBAC SBA Communications	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$160.12 -1.7%	$208.00 ➝ $207.00	Overweight
SBRE Sabre Insurance Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 176 +2.2%	GBX 200 ➝ GBX 205	Buy
SCR Strathcona Resources	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$38.78 +0.5%	C$67.00 ➝ C$63.00	Outperform
SFD Smithfield Foods	Initiated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pooran Sharma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.72 -1.5%	$22.00	Equal Weight
SGR.UN Slate Grocery REIT	Downgraded by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.61 +0.3%	C$8.00 ➝ C$13.00	Underperform ➝ Tender
SGR.UN Slate Grocery REIT	Downgraded by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.61 +0.3%	C$12.00 ➝ C$13.00	Hold ➝ Sell
SGRY Surgery Partners	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.87 -3.7%	$19.00	Outperform
SJ Stella-Jones	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$67.45 -3.2%	C$79.00 ➝ C$76.00
SKY Champion Homes	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Batory Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.79 -1.0%		Market Perform
SMMT Summit Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.91 +3.2%		Neutral
SOC Sable Offshore	Target Lowered by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Mariani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.45 +1.4%	$11.00 ➝ $10.00	Buy
SOLS Solstice Advanced Mat	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.32 +0.6%	$82.00	Outperform
SPCX SpaceX	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$150.86 +1.1%		Buy
SRPT Sarepta Therapeutics	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.22 -2.3%	$23.00 ➝ $20.00	Neutral
SSTI SoundThinking	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.31 +1.2%	$9.00
SSTI SoundThinking	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Baldry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.31 +1.2%	$9.00	Buy ➝ Neutral
SSTI SoundThinking	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.31 +1.2%		Market Perform
STC Sangoma Technologies	Downgraded by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.97 -0.1%	C$8.00 ➝ C$7.35	Buy ➝ Sell
STC Sangoma Technologies	Downgraded by	Acumen Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.97 -0.1%	C$11.00 ➝ C$7.40	Buy ➝ Tender
STLJF Stella-Jones	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$47.91 -0.4%		Sector Perform
STRL Sterling Infrastructure	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manish A. Somaiya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$491.78 -2.6%	$742.00	Overweight
STRO Sutro Biopharma	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.11 +0.1%	$49.00	Overweight
SU Suncor Energy	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$96.50 +0.7%	C$118.00 ➝ C$146.00	Outperform
SXT Sensient Technologies	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.54 +1.4%	$155.00 ➝ $157.00	Buy
SYK Stryker	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Wise Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$276.07 -1.0%	$360.00 ➝ $330.00	Buy
T TELUS	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$11.95 +3.3%	C$15.00 ➝ C$13.00
TCBX Third Coast Bancshares	Initiated by	Brean Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.27 -0.8%	$47.00	Neutral
TDG Transdigm Group	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,083.76 -1.5%	$1,450.00 ➝ $1,210.00	Equal Weight
TECX Tectonic Therapeutic	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.29 -0.2%		Buy
TECX Tectonic Therapeutic	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leland Gershell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.29 -0.2%	$80.00	Outperform
TFII TFI International	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Walter Spracklin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.82 -1.7%	$171.00 ➝ $144.00	Outperform
TIH Toromont Industries	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$226.98 +0.4%	C$250.00	Buy
TLPFY Teleperformance	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.64 -2.2%		Neutral
TNDM Tandem Diabetes Care	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.31 -1.6%	$24.00 ➝ $20.00	Neutral
TNZ Tenaz Energy	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$63.59 -0.1%	C$91.00 ➝ C$100.00	Outperform
TPFG The Property Franchise Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 417 +0.5%	GBX 640	Buy
TRAX First Tracks Biotherapeutics	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Nash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.44 -1.5%	$50.00	Buy
TROX Tronox	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Roberts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.96 -0.9%	$5.50 ➝ $4.50	Underperform
TRP TC Energy	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Mackay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.93 -0.6%	$71.00	Neutral ➝ Buy
TVE Tamarack Valley Energy	Target Set by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$13.18 +1.1%	C$17.00	Sector Outperform
UBER Uber Technologies	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nikhil Devnani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.63 -1.1%		Outperform
UEC Uranium Energy	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.45 +1.7%	$26.75	Buy
UFPI UFP Industries	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Batory Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.22 -2.0%		Market Perform
VALE Vale	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rodolfo Angele Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.43 +1.0%	$21.00 ➝ $22.00	Overweight
VIK Viking	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.42 -0.4%		Buy
VSVS Vesuvius	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 472.80 +1.2%	GBX 450 ➝ GBX 550	Buy
W Wayfair	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.50 +0.5%	$133.00	Overweight
WATR Water Intelligence	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 320 -6.6%	GBX 515	Buy
WCP Whitecap Resources	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.59 +0.5%	C$26.00 ➝ C$27.00	Outperform
WDAY Workday	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$190.46 +0.7%		Overweight
WHD Cactus	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.42 -2.0%	$75.00 ➝ $73.00	Neutral
WHWK Whitehawk Therapeutics	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.76 +0.8%	$9.00
WJX Wajax	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$36.42 +0.4%	C$45.00	Buy
WLK Westlake	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.48 -1.4%	$85.00 ➝ $67.00	Neutral
WSP WSP Global	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.24 +1.6%	C$219.00 ➝ C$216.00	Outperform
WSP WSP Global	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.24 +1.6%	C$280.00 ➝ C$230.00	Buy
WSP WSP Global	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.24 +1.6%	C$280.00 ➝ C$275.00	Outperform
WSP WSP Global	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.24 +1.6%	C$304.00 ➝ C$303.00	Outperform
WTE Westshore Terminals Investment	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$43.54 +0.2%	C$44.00 ➝ C$47.00
WTTR Select Water Solutions	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.82 +2.5%	$28.00	Buy
WTTR Select Water Solutions	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Larkin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.82 +2.5%	$24.00 ➝ $28.00	Buy
WWD Woodward	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.59 -0.4%	$440.00 ➝ $430.00	Overweight
XNCR Xencor	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.95 -0.2%	$55.00	Overweight
YGR Yangarra Resources	Upgraded by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.44 -0.7%	C$1.80 ➝ C$2.20	Sector Perform ➝ Outperform
ZBIO Zenas BioPharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.97 +0.8%	$44.00	Buy
ZBIO Zenas BioPharma	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Fan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.97 +0.8%	$45.00	Outperform
ZBIO Zenas BioPharma	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yatin Suneja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.97 +0.8%	$55.00	Buy
ZBIO Zenas BioPharma	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.97 +0.8%	$41.00 ➝ $48.00	Buy
ZNTL Zentalis Pharmaceuticals	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.77 +2.2%	$5.00	Equal Weight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:01 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings